A method for estimating the probability of adverse drug reactions

Naranjo, C A, Busto, U, Sellers, E M, Sandor, P, Ruiz, I, Roberts, E A, Janecek, E, Domecq, C +1 more·1981·Clinical Pharmacology and Therapeutics
DOI 10.1038/clpt.1981.154

Cited by (1,014)

Items 101–200 of 1,014

  1. Development and Inter-Rater Reliability of the Liverpool Adverse Drug Reaction Causality Assessment Tool
    Ruairi M Gallagher, Jamie J Kirkham, Jennifer R. Mason, Kim A Bird, Paula Ruth Williamson, Anthony J Nunn, Mark A. Turner, Rosalind Louise Smyth, Munir Pirmohamed · 2011 · PLoS ONE
  2. Cost of Opioid-Related Adverse Drug Events in Surgical Patients
    Gary M. Oderda, R. Scott Evans, James F. Lloyd, Arthur G. Lipman, Connie Chen, Michael A. Ashburn, John Patrick Burke, Matthew H. Samore · 2003 · Journal of Pain and Symptom Management
  3. Clinical and Economic Impact of Adverse Drug Reactions in Hospitalized Patients
    Dong‐Churl Suh, Betsy S Woodall, Soung-Kook Shin · 2000 · Annals of Pharmacotherapy
  4. Drug Interaction between St. John's Wort and Cyclosporine
    Gary W. Barone, Bill J. Gurley, Beverley L. Ketel, Meredith L Lightfoot, Sameh R. Abul‐Ezz · 2000 · Annals of Pharmacotherapy
  5. Linezolid: a review of safety and tolerability
    Donald Cuong Vinh, Ethan Rubinstein · 2009 · Journal of Infection
  6. Homeopathic clinical case reports: Development of a supplement (HOM-CASE) to the CARE clinical case reporting guideline
    Robbert A. van Haselen · 2016 · Complementary Therapies in Medicine
  7. The economic burden of preventable adverse drug reactions: a systematic review of observational studies
    Dario Formica, Janet Sultana, Paola Maria Cutroneo, Simona Lucchesi, Regina Marisa Angelica, Salvatore Crisafulli, Ylenia Ingrasciotta, Francesco Salvo, Edoardo Spina, Gianluca Trifirò · 2018 · Expert Opinion on Drug Safety
  8. Computerized surveillance of adverse drug events in hospital patients
    David C. Classen · 2005 · BMJ Quality & Safety
  9. Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology Assessment and beyond: The Advance Value Framework
    Aris Angelis, Panos G. Kanavos · 2017 · Social Science & Medicine
  10. Drug-Induced Liver Injury
    Kurt W. Fisher, Raj Vuppalanchi, Romil Saxena · 2015 · Archives of Pathology & Laboratory Medicine
  11. Electronic Prescribing Improves Medication Safety in Community-Based Office Practices
    Rainu Kaushal, Lisa M. Kern, Yolanda Barrón, Jill Quaresimo, Erika L. Abramson · 2010 · Journal of General Internal Medicine
  12. Statin‐Associated Adverse Cognitive Effects: Survey Results from 171 Patients
    Marcella A. Evans, Beatrice Alexandra Golomb · 2009 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  13. Evaluation and outcomes of patients with palpitations
    Weber, Barbara E., Kapoor, Wishwa N. · 1996 · The American Journal of Medicine
  14. Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and granulysin
    Wen‐Hung Chung, Wan‐Chun Chang, SOPHIE LENA STOCKER, Chiun‐Gung Juo, Garry G. Graham, M.H. Lee, Kenneth M. Williams, Ya‐Chung Tian, Kuo-Chang Juan, Yeong‐Jian Jan Wu et al. · 2014 · Annals of the Rheumatic Diseases
  15. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital
    J JOSE, P RAO · 2006 · Pharmacological Research
  16. Adverse drug reaction monitoring in a secondary care hospital in South India
    R. Arulmani, S.D. Rajendran, B. Suresh · 2007 · British Journal of Clinical Pharmacology
  17. Causality assessment methods in drug induced liver injury: Strengths and weaknesses
    Miren García‐Cortés, Camilla M. Stephens, M. Isabel Lucena, Alejandra Fernández Castañer, Raúl J. Andrade · 2011 · Journal of Hepatology
  18. Concealed Renal Insufficiency and Adverse Drug Reactions in Elderly Hospitalized Patients
    Andrea Corsonello · 2005 · Archives of Internal Medicine
  19. Drug-Induced Cognition Disorders in the Elderly: Incidence, Prevention and Management
    Gray, Shelly L., Lai, Katie V., Larson, Eric B. · 1999 · Drug Safety
  20. An Update on Drug-induced Liver Injury
    Harshad C. Devarbhavi · 2012 · Journal of Clinical and Experimental Hepatology
  21. A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300–600 mg/day versus benzbromarone 100–200 mg/day in patients with gout
    M.K. Reinders, CEES J. HAAGSMA, Tim Jansen · 2008 · Annals of the Rheumatic Diseases
  22. Illustration of the Weibull Shape Parameter Signal Detection Tool Using Electronic Healthcare Record Data
    Odile Sauzet, Alfonso Carvajal, Antonio Escudero · 2013 · Drug Safety
  23. Potentiation of Warfarin by Dong Quai
    Robert Lee Page II, Julie D Lawrence · 1999 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  24. The Impact of Unlicensed and Off-Label Drug Use on Adverse Drug Reactions in Paediatric Patients
    Antje C. Neubert, Harald Dormann, Jutta Weiss, Tobias Egger, Manfred Criegee‐Rieck, Wolfgang Rascher, Kay Brune, Burkhard Hinz · 2004 · Drug Safety
  25. Practical guidelines for diagnosis and early management of drug-induced liver injury
    Kazuto Tajiri, Yukihiro Shimizu · 2008 · World Journal of Gastroenterology
  26. Drug‐Related Visits to the Emergency Department: How Big Is the Problem?
    Payal Patel, Peter J. Zed · 2002 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  27. Mechanisms for Linezolid-Induced Anemia and Thrombocytopenia
    Wendy B. Bernstein, Richard F. Trotta, James T. Rector · 2003 · Annals of Pharmacotherapy
  28. Intra‐arterial transplantation of HLA‐matched donor mesoangioblasts in Duchenne muscular dystrophy
    Giulio Cossu, Stefano Carlo Previtali, Sara Napolitano, Maria Pia Cicalese, Francesco Saverio Tedesco, Francesca Nicastro, Maddalena Noviello, Urmas Roostalu, Maria Grazia Natali Sora, Marina Scarlato et al. · 2015 · EMBO Molecular Medicine
  29. Adverse-Drug-Reaction-Related Hospitalisations in Developed and Developing Countries: A Review of Prevalence and Contributing Factors
    Mulugeta Tarekegn Angamo, Leanne Chalmers, Colin Michael Curtain · 2016 · Drug Safety
  30. Adverse Drug Reactions in Hospitalized Patients: Results of the FORWARD (Facilitation of Reporting in Hospital Ward) Study
    Claudia Giardina, Paola Maria Cutroneo, Eleonora Mocciaro · 2018 · Frontiers in Pharmacology
  31. Frequency of adverse drug reactions in hospitalized patients: a systematic review and meta‐analysis
    Ana Miguel, Luís Filipe Azevedo, Maísa Barroso de Araújo, Altamiro Costa‐Pereira · 2012 · Pharmacoepidemiology and Drug Safety
  32. Clinicopathlogical features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan
    C‐C Chiou, L‐C Yang, Wen‐Hung Chung · 2008 · Journal of the European Academy of Dermatology and Venereology
  33. How to write a patient case report
    Henry Cohen · 2006 · American Journal of Health-System Pharmacy
  34. The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use
    Robert Lee Page II, J. Mark Ruscin · 2006 · The American Journal of Geriatric Pharmacotherapy
  35. Medication reconciliation for reducing drug-discrepancy adverse events
    Kenneth S. Boockvar, Heather Carlson LaCorte, V Giambanco, Bella Fridman, Albert L. Siu · 2006 · The American Journal of Geriatric Pharmacotherapy
  36. United States Pharmacopeia Safety Evaluation of Spirulina
    Marles, Robin J., Barrett, Marilyn L., Barnes, Joanne, Chavez, Mary L., Gardiner, Paula, Ko, Richard, Mahady, Gail B., Dog, Tieraona Low, Sarma, Nandakumara D., Giancaspro, Gabriel I. et al. · 2011 · Critical Reviews in Food Science and Nutrition
  37. Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report
    Sergey E. Borisov, Edvardas Danila, Andrei Maryandyshev, Margareth Pretti Dalcolmo, Skaidrius Miliauskas, Līga Kukša, Selene Manga, Alena M. Skrahina, Saulius Diktanas, Luigi Ruffo Codecasa et al. · 2019 · European Respiratory Journal
  38. Adverse drug events in emergency department patients
    John William Hafner, Steven M. Belknap, Marc D. Squillante, Kay A. Bucheit · 2002 · Annals of Emergency Medicine
  39. Impact of inappropriate drug use among hospitalized older adults
    Graziano Onder, Francesco Landi, Rosa Liperoti, Daniela Fialová, Giovanni Gambassi, Roberto Bernabei · 2005 · European Journal of Clinical Pharmacology
  40. The impact of computerized provider order entry on medication errors in a multispecialty group practice
    Emily Beth Devine, Ryan N. Hansen, Jennifer L. Wilson‐Norton, N M Lawless, Albert W. Fisk, David King Blough, Diane P. Martin, Sean D. Sullivan · 2010 · Journal of the American Medical Informatics Association
  41. Drug-induced and iatrogenic infiltrative lung disease
    Philippe Camus, Philippe Bonniaud, Annlyse Fanton · 2004 · Clinics in Chest Medicine
  42. Phenotype standardization for drug-induced kidney disease
    Ravindra L. Mehta, Linda Awdishu, Andrew Davenport · 2015 · Kidney International
  43. Guillain‐Barré Syndrome following ChAdOx1‐S / nCoV ‐19 Vaccine
    Boby Varkey Maramattom, Parameswaran Krishnan, Reji Paul, Sandeep Padmanabhan, Soumya Cherukudal Vishnu Nampoothiri, Akheel A. Syed, Halinder S. Mangat · 2021 · Annals of Neurology
  44. Drug-induced interstitial lung disease
    Paolo Spagnolo, Philippe Bonniaud, Giulio Rossi, Nicola Sverzellati, Vincent Cottin · 2022 · European Respiratory Journal
  45. Recovery of Cognitive Function After Remifentanil-Propofol Anesthesia: A Comparison with Desflurane and Sevoflurane Anesthesia
    Brita Larsen, Anette Seitz, R. Larsen · 2000 · Anesthesia & Analgesia
  46. Drug-induced psoriasis: clinical perspectives
    Deepak M.W. Balak, Enes Hajdarbegovic · 2017 · Psoriasis Targets and Therapy
  47. HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms
    Katherine C. Konvinse, Jason Anthony Trubiano, Rebecca K. Pavlos, IAN R. JAMES, Christian M. Shaffer, Cosmin Adrian Bejan, Ryan J. Schutte, David A. Ostrov, Mark A. Pilkinton, Misha A. Rosenbach et al. · 2019 · Journal of Allergy and Clinical Immunology
  48. Evaluation of Naranjo Adverse Drug Reactions Probability Scale in causality assessment of drug‐induced liver injury
    Miren García‐Cortés, M. Isabel Lucena, Ketevan Pachkoria, Yolanda Borraz, R. Hidalgo, Raúl J. Andrade, ON BEHALF OF THE SPANISH GROUP FOR THE STUDY OF DRUG‐INDUCED LIVER DISEASE (GRUPO DE ESTUDIO PARA LAS HEPATOPATÍAS ASOCIADAS A MEDICAMENTOS, GEHAM) · 2008 · Alimentary Pharmacology & Therapeutics
  49. A review of causal inference for biomedical informatics
    Samantha Kleinberg, George M. Hripcsak · 2011 · Journal of Biomedical Informatics
  50. Incidence and Costs of Adverse Drug Reactions During Hospitalisation
    Harald Dormann, Uta Muth‐Selbach, Sabine Krebs, Manfred Criegee‐Rieck, Irmgard Tegeder, Hans T. Schneider, Eckhart G. Hahn, Micha Levy, Kay Brune, Gerd Geißlinger · 2000 · Drug Safety
  51. United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity
    Gail B. Mahady, Tieraona Low Dog, Marilyn L. Barrett, Mary L. Chavez, Paula M. Gardiner, Richard Ko, Robin J. Marles, Linda S. Pellicore, Gabriel I. Giancaspro, Dandapantula N. Sarma · 2008 · Menopause The Journal of The North American Menopause Society
  52. Do Atypical Antipsychotics Cause Stroke?
    N. Herrmann, K. Lanctôt · 2005 · CNS Drugs
  53. Adverse drug reaction‐related hospitalisations: a population‐based cohort study
    Cornelis S. van der Hooft, Jeanne P. Dieleman, Claire Siemes · 2008 · Pharmacoepidemiology and Drug Safety
  54. Interleukin-15 Is Associated with Severity and Mortality in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
    Shih‐Chi Su, Maja Mockenhaupt, P. Wolkenstein et al. · 2016 · Journal of Investigative Dermatology
  55. Cumulative incidence, risk factors, and management of atrial fibrillation in patients receiving ibrutinib
    Tracy E. Wiczer, Lauren B. Levine, Jessica Brumbaugh, Jessica Coggins, Qiuhong Zhao, Amy S. Ruppert, Kerry Anne Rogers, Anli McCoy, Luay Mousa, Avirup Guha et al. · 2017 · Blood Advances
  56. Preventing Adverse Drug Events in Hospitalized Patients
    R. Scott Evans, Stanley L. Pestotnik, David C. Classen, Susan D. Horn, Sheron B. Bass, John Patrick Burke · 1994 · Annals of Pharmacotherapy
  57. How safe is the use of thiazolidinediones in clinical practice?
    Rizos, CV, Elisaf, Moses, Mikhailidis, DP, Liberopoulos, EN · 2009 · Expert Opinion on Drug Safety
  58. Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies
    Chun‐Bing Chen, Ming-Ying Wu, Chau Yee Ng, Chun‐Wei Lu, Jennifer Wu, Pei‐Han Kao, Chan‐Keng Yang, Meng‐Ting Peng, Chen‐Yang Huang, Wen-Cheng Chang et al. · 2018 · Cancer Management and Research
  59. Frequency, Severity, and Treatment of Agitation in Young versus Elderly Patients in the ICU
    Fraser, Gilles L., Prato, B. Stephen, Riker, Richard R., Berthiaume, Donald, Wilkins, Micheline L. · 2000 · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
  60. Brief Communication: Severe Hepatotoxicity of Telithromycin: Three Case Reports and Literature Review
    Kimberly D. Clay, John S. Hanson, Scott D. Pope, Richard W. Rissmiller, Preston P. Purdum, Peter M. Banks · 2006 · Annals of Internal Medicine
  61. Systematic review: sprue-like enteropathy associated with olmesartan
    Gianluca Ianiro, Stefano Bibbò, Massimo Montalto · 2014 · Alimentary Pharmacology & Therapeutics
  62. Drug‐Related Hospital Admissions
    Kent M. Nelson, Robert L. Talbert · 1996 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  63. Liver toxicity related to herbs and dietary supplements: Online table of case reports. Part 2 of 5 series
    Amy Christine Brown · 2016 · Food and Chemical Toxicology
  64. Assessment of drug-induced hepatotoxicity in clinical practice: A challenge for gastroenterologists
    Raúl J Andrade · 2007 · World Journal of Gastroenterology
  65. Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps
    Rolf Teschke, Axel Eickhoff · 2015 · Frontiers in Pharmacology
  66. Evolving epidemiology of drug-induced seizures reported to a poison control center system
    Josef G. Thundiyil, Thomas E. Kearney, Kent R. Olson · 2007 · Journal of Medical Toxicology
  67. Hallucinations and Other Psychotic Symptoms Associated With the Use of Attention-Deficit/Hyperactivity Disorder Drugs in Children
    Mosholder, Andrew D., Gelperin, Kate, Hammad, Tarek A., Phelan, Kathleen, Johann-Liang, Rosemary · 2009 · Pediatrics
  68. Drug induced nightmares—an etiology based review
    James Frederic Pagel, P. Helfter · 2003 · Human Psychopharmacology Clinical and Experimental
  69. Incidence and cost of medication harm in older adults following hospital discharge: a multicentre prospective study in the UK
    Nikesh Parekh, Khalid Ali, Jennifer M Stevenson, Graham Davies, Rebekah Schiff, Tischa J. M. van der Cammen, Jatinder Harchowal, James P. Raftery, Chakravarthi Rajkumar, on behalf of the PRIME study group · 2018 · British Journal of Clinical Pharmacology
  70. Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study
    KJ Patel, MS Kedia, Divya Bajpai · 2007 · BMC Clinical Pharmacology
  71. Evidence-based toxicology: a comprehensive framework for causation
    Philip S. Guzelian, Michael S Victoroff, N. Christine Halmes, Robert C. James, Christopher P. Guzelian · 2005 · Human & Experimental Toxicology
  72. Management of patients with palpitations: a position paper from the European Heart Rhythm Association
    Raviele, Antonio, Giada, Franco, Bergfeldt, Lennart, Blanc, Jean Jacques, Blomstrom-Lundqvist, Carina, Mont, Lluis, Morgan, John M., Raatikainen, M.J. Pekka, Steinbeck, Gerhard, Viskin, Sami et al. · 2011 · Europace
  73. Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice
    Jonny Peter, Rannakoe J. Lehloenya, Sipho Kenneth Dlamini, Kimberly Risma, Katie D. White, Katherine C. Konvinse, Elizabeth Jane Phillips · 2017 · The Journal of Allergy and Clinical Immunology In Practice
  74. Adverse interactions between herbal and dietary substances and prescription medications: a clinical survey.
    Thomas M. Bush, Keith S Rayburn, Sandra W Holloway, Deanna S Sanchez-Yamamoto, Blaine L Allen, Tiffany Lam, Brian K So, De H Tran, Elizabeth R Greyber, Sophia Kantor et al. · 2007 · PubMed
  75. Challenges in Systematic Reviews That Assess Treatment Harms
    Roger Chou, Mark Helfand · 2005 · Annals of Internal Medicine
  76. Adverse Events After Discontinuing Medications in Elderly Outpatients
    Taylor Graves · 1997 · Archives of Internal Medicine
  77. Adverse Events After the Use of Benznidazole in Infants and Children With Chagas Disease
    Jaime Altcheh, Guillermo Moscatelli, Samanta Moroni · 2010 · PEDIATRICS
  78. Self-Reported Adverse Drug Reactions and Related Resource Use
    Elizabeth A. Chrischilles, Ellen T. Segar, Robert B. Wallace · 1992 · Annals of Internal Medicine
  79. Genotype-Guided Dosing of Coumarin Derivatives: The European Pharmacogenetics of Anticoagulant Therapy (EU-PACT) Trial Design
    Rianne MF van Schie, Mia Wadelius, Farhad Kamali et al. · 2009 · Pharmacogenomics
  80. Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey
    Raphaèle Séror, Christophe Richez, Christelle Sordet et al. · 2013 · Lara D. Veeken
  81. Does Therapeutic Use of Acetaminophen Cause Acute Liver Failure?
    Richard C. Dart, Elise J. Bailey · 2007 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  82. Experiences with Adverse Drug Reaction Reporting by Patients
    Florence P. A. M. van Hunsel, Linda Härmark, Shanthi Narayan Pal, Sten Olsson, Kees van Grootheest · 2011 · Drug Safety
  83. Drugs That Induce or Cause Deterioration of Myasthenia Gravis: An Update
    Shuja Sheikh, Usman Alvi, Betty C. Soliven, Kourosh Rezania · 2021 · Journal of Clinical Medicine
  84. International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma
    Paula Rodríguez‐Otero, Saad Z. Usmani, Adam D. Cohen, Niels W.C.J. van de Donk, Xavier P Leleu, Jaime Gállego Pérez‐Larraya, Salomon Manier, Ajay K. Nooka, María‐Victoria Mateos, Hermann Einsele et al. · 2024 · The Lancet Oncology
  85. Drug‐related Hepatotoxicity and Acute Liver Failure
    Karen F. Murray, Nedim Hadžić, Stefan Wirth, Mikelle D. Bassett, Deirdre Anne Kelly · 2008 · Journal of Pediatric Gastroenterology and Nutrition
  86. Good Clinical Outcomes but High Rates of Adverse Reactions during Linezolid Therapy for Serious Infections: a Proposed Protocol for Monitoring Therapy in Complex Patients
    Emma Jane Bishop, Sharmila Melvani, Benjamin P. Howden, Patrick G. P. Charles, Michael Lindsay Grayson · 2006 · Antimicrobial Agents and Chemotherapy
  87. Circulating KL-6 levels in patients with drug induced pneumonitis
    Hiroshi Ohnishi · 2003 · Thorax
  88. Prevalence and factors associated with polypharmacy in older people with cancer
    Justin P. Turner, Sepehr Shakib, Nimit Singhal, Jonathon Hogan-Doran, Robert J. Prowse, Sally Johns, J. Simon Bell · 2014 · Supportive Care in Cancer
  89. Fluorouracil-Induced Neurotoxicity
    Noor A. Pirzada, Imran Ali, Rima M. Dafer · 2000 · Annals of Pharmacotherapy
  90. The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A randomized open label trial
    Luca Gallelli, Olimpio Galasso, D. Falcone, Stephen R. Southworth, Marta Greco, Valeria Ventura, Patrizia Romualdi, Antonio Corigliano, Rosa Terracciano, Rocco Savino et al. · 2013 · Osteoarthritis and Cartilage
  91. Adverse drug reaction and causality assessment scales
    SyedAhmed Zaki · 2011 · Lung India
  92. Herbal hepatotoxicity: a tabular compilation of reported cases
    Rolf Teschke, Albrecht Wolff, Christian Frenzel, Johannes Schulze, Axel Eickhoff · 2012 · Liver International
  93. Impact of an integrated antibiotic allergy testing program on antimicrobial stewardship: a multicenter evaluation.
    Trubiano, Jason A, Thursky, Karin A, Stewardson, Andrew J, Urbancic, Karen, Worth, Leon J, Jackson, Cheryl, Stevenson, Wendy, Sutherland, Michael, Slavin, Monica A, Grayson, M Lindsay et al. · 2017 · Clinical Infectious Diseases
  94. A study of agreement between the Naranjo algorithm and WHO-UMC criteria for causality assessment of adverse drug reactions
    RenukaP Munshi, Mahesh Namdeo Belhekar, Santosh Ramesh Taur · 2014 · Indian Journal of Pharmacology
  95. Drug-induced liver injury: Is it somehow foreseeable?
    Tarantino, Giovanni, Minno, Matteo Nicola Dario Di, Capone, Domenico · 2009 · World Journal of Gastroenterology
  96. Adverse Drug Events in Elderly Patients Receiving Home Health Services following Hospital Discharge
    Shelly L. Gray, Jane Mahoney, David King Blough · 1999 · Annals of Pharmacotherapy
  97. Detecting Potential Adverse Drug Reactions Using a Deep Neural Network Model
    Chi-Shiang Wang, Pei-Ju Lin, Ching‐Lan Cheng, Shu-Hua Tai, Yea‐Huei Kao Yang, Jung-Hsien Chiang · 2018 · Journal of Medical Internet Research
  98. Statins and Inflammation: New Therapeutic Opportunities in Psychiatry
    Sung‐Wan Kim, Hee‐Ju Kang, Min Jhon, Ju‐Wan Kim, Ju‐Yeon Lee, Adam J. Walker, Bruno Agustini, Jae‐Min Kim, Michael Berk · 2019 · Frontiers in Psychiatry
  99. Physician Response to Patient Reports of Adverse Drug Effects
    Beatrice Alexandra Golomb, John J. McGraw, Marcella A. Evans, Joel E. Dimsdale · 2007 · Drug Safety
  100. Chemotherapy-induced adverse drug reactions in oncology patients: A prospective observational survey
    Deepti Chopra, Harmeet Singh Rehan, Vibha Sharma · 2016 · Indian Journal of Medical and Paediatric Oncology